精密生物科学GAAP每股收益为-2.13美元，相差0.56美元

2025-08-07 19:56

Precision BioSciences press release (NASDAQ:DTIL): Q2 GAAP EPS of -$2.13 misses by $0.56.
Extended expected cash runway to the second half of 2027 providing more than two years of operating cash

More on Precision BioSciences

Precision BioSciences Q2 2025 Earnings Preview
Precision BioSciences gets FDA rare disease status for DMD treatment, stock jumps 10%
Seeking Alpha’s Quant Rating on Precision BioSciences
Historical earnings data for Precision BioSciences
Financial information for Precision BioSciences